Acetaminophen (or equivalent) + Dexamethasone (or equivalent) + Histamine H1 Receptor Antagonist + Histamine H2 Receptor Antagonist + MK-2010 + Steroid mouthwash (dexamethasone or equivalent) + Sacituzumab tirumotecan + Epinephrine
1 treatment and condition followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Acetaminophen (or equivalent) + Dexamethasone (or equivalent) + Histamine H1 Receptor Antagonist + Histamine H2 Receptor Antagonist + MK-2010 + Steroid mouthwash (dexamethasone or equivalent) + Sacituzumab tirumotecan + Epinephrine for neoplasms | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |